Four Recommendations to Efficiently and Equitably Accelerate the COVID-19 Vaccine Rollout

Document Type

Article

Year

2021

Abstract

Although scientists have created highly effective and safe vaccines for the SARS-CoV-2 virus (COVID-19) and pharmaceutical companies are rapidly mass-producing them, the US continues to face an enormous distribution logistics problem, made more challenging by uncoordinated government planning and response. As hospitalizations and deaths recently set all-time-high records across the country, widespread delays in distribution are morally unacceptable.

Share

COinS